参考文献/References:
［1］ BRAY F，FERLAY J，SOERJOMATARAM I，et al．Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］ ．CA Cancer J Clin,2018,68 (6):394-424.
［2］ SIEGEL R L，MILLER K D，JEMAL A．Cancer statistics,2017［J］.CA Cancer J Clin,2017,67(1):7-30.
［3］ VARGAS A J，THOMPSON P A．Diet and nutrient factors in colorectal cancer risk［J］．Nutr Clin Pract,2012,27(5):613-23.
［4］ ARNOLD M，SIERRA M S，LAVERSANNE M，et al．Global patterns and trends in colorectal cancer incidence and mortality［J］．Gut,2017,66(4):683-691.
［5］ LABIANCA R，NORDLINGER B，BERETTA G D， et al．Early colon cancer:ESMO clinical practice guidelines for diagnosis,treatment and follow-up［J］．Ann Oncol,2013,24(Suppl 6):vi64- vi72.
［6］ BENSON A B，VENOOK A P，AL-HAWARY M M，et al．Rectal cancer,version 2.2018,NCCN Clinical Practice Guidelines in Oncology［J］．J Natl Compr Canc Netw,2018,16(7):874-901.
［7］ SHINAGAWA T，TANAKA T，NOZAWA H，et al．Comparison of the guidelines for colorectal cancer in Japan,the USA and Europe［J］．Ann Gastroenterol Surg,2017,2(1):6-12.
［8］ FRANCIOSI M，LUCISANO G，LAPICE E，et al．Metformin therapy and risk of cancer in patients with type 2 diabetes:systematic review［J］．PLoS One,2013,8(8):e71583.
［9］ KANADIYA M K，GOHEL T D，SANAKA M R，et al．Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy［J］．J Diabetes Complications,2013,27(5):463-466.
［10］ KHAWAJA M R，NICK A M,MADHUSUDANANNAIR V，et al．Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers［J］．Cancer Chemother Pharmacol,2016,77(5):973-977.
［11］ SEHDEV A，SHIH Y T，VEKHTER B，et al．Metformin forprimary colorectal cancer prevention in patients with diabetes:a case-control study in a US population［J］．Cancer,2015,121(7):1071-1078.
［12］ SIEGEL R L,MILLER K D,JEMAL A．Cancer statistics,2019［J］．CA Cancer J Clin,2019,69(1):7-34.
［13］ MOHAMED SUHAIMI N A,PHYO W M,YAP H Y，et al．Metformin inhibits cellular proliferation and bioenergetics in colorectal cancer patient-derived xenografts［J］．Mol Cancer Ther,2017,16 (9):2035-2044.
［14］ GEAGEA A G，RIZZO M，JURJUS A，et al．A novel therapeutic approach to colorectal cancer in diabetes:role of metformin and rapamycin［J］．Oncotarget,2019,10(13):1284-1305.
［15］ JALVING M，GIETEMA J A,LEFRANDT J D，et al．Metformin:taking away the candy for cancer［J］．Eur J Cancer,2010,46(13):2369-2380.
［16］ PIEROTTI M A,BERRINO F,GARIBOLDI M，et al．Targeting metabolism for cancer treatment and prevention:metformin,an old drug with multi-faceted effects［J］．Oncogene,2013,32(12):1475-1487.
［17］ JONES R G，PLAS D R,KUBEK S，et al．AMP-activated protein kinase induces a p53-dependent metabolic checkpoint［J］．Mol Cell,2005,18(3):283-293.
［18］ BUZZAI M，JONES R G,AMARAVADI R K，et al．Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth［J］．Cancer Res,2007,67(14):6745-6752.
［19］ ARAI M，UCHIBA M，KOMURA H，et al．Metformin,an antidiabetic agent,suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expre-ssion in human monocytes in vitro［J］．J Pharmacol Exp Ther,2010,334(1):206-213.
［20］ ALGIRE C，MOISEEVA O，DESCH E＾NES-SIMARD X，et al．Metformin reduces endogenous reactive oxygen species and associated DNA damage［J］．Cancer Prev Res (Phila),2012,5(4):536-543.
［21］ ALGIRE C Y，AMREIN L，ZAKIKHANI M，et al．Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase［J］．Endocr Relat Cancer,2010,17(2):351-360.
［22］ JIA Y，ZENG Y，LIU X F，et al．Metformin prevents DMH-induced colorectal cancer in diabetic rats by reversing the warburg effect［J］．Cancer Med,2015,4(11):1730-1741.
［23］ KOH S J，KIM J M，KIM I K，et al．Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer［J］．J Gastroenterol Hepatol,2014,29(3):502-510.
［24］ NANGIA-MAKKER P，YU Y J，VASUDEVAN A，et al．Metformin:a potential therapeutic agent for recurrent colon cancer［J］．PLoS One,2014,9(1):e84369.
［25］ ZAAFAR D K,ZAITONE S A,MOUSTAFA Y M．Role of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice:effect on tumor angiogenesis and cell proliferation［J］．PLoS One,2014,9(6):e100562.
［26］ ROSATO V，TAVANI A，GRACIA-LAVEDAN E，et al．Type 2 diabetes,antidiabetic medications,and colorectal cancer risk:two case-control studies from Italy and Spain［J］．Front Oncol,2016,6:210.
［27］ NIE Z，ZHU H，GU M．Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin:a meta-analysis［J］．Pharm Biol,2016,54(11):2636-2642.
［28］ MEI Z B，ZHANG Z J，LIU C Y，et al．Survival benefits of metformin for colorectal cancer patients with diabetes:a systematic review and meta-analysis［J］．PLoS One,2014,9(3):e91818.
［29］ JUNG Y S，PARK C H，EUN C S，et al．Metformin use and the risk of colorectal adenoma:a systematic review and meta-analysis［J］．J Gastroenterol Hepatol,2017,32(32):957-965.
［30］ MANSOURIAN M,KARIMI R,VASEGHI G．Different effects of metformin and insulin on primary and secondary chemoprevention of colorectal adenoma in diabetes type 2:traditional and bayesian meta-analysis［J］．EXCLI J,2018,17:45-56.
［31］ HIGURASHI T，HOSONO K，TAKAHASHI H，et al．Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes:a multicentre double-blind,placebo-controlled,randomised phase 3 trial［J］．Lancet Oncol,2016,17(14):475-483.
［32］ CHO Y H，KO B M，KIM S H，et al．Does metformin affect the incidence of colonic polyps and adenomas in patients with type 2 diabetes mellitus［J］．Intest Res,2014,12(2):139-145.
［33］ HOSONO K，ENDO H，TAKAHASHI H，et al．Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial［J］．Cancer Prev Res (Phila),2010,3(9):1077-1083.
［34］ ZHANG P P，LI H，TAN X H，et al．Association of metformin use with cancer incidence and mortality:a meta-analysis［J］．Cancer Epidemiol,2013,37(3):207-218.
［35］ MEI Z B，ZHANG Z，LIU C Y，et al．Survival benefits of metformin for colorectal cancer patients with diabetes:a systematic review and meta-analysis［J］．PLoS One,2014,9(3):e91818.
［36］ LEE D J U N，KIM B，LEE J H，et al．The effect of metformin on responses to chemotherapy and survival in stage IV colorectal cancer with diabetes［J］．Korean J Gastroenterol,2012,60(6):355-361.
［37］ OH B Y，PARK Y A，HUH J W，et al．Metformin enhances the response to radiotherapy in diabetic patients with rectal cancer［J］．J Cancer Res Clin Oncol,2016,142(6):1377-1385．
［38］ KIM S H，KIM S C，KU J L．Metformin increases chemo-sensitivity via gene downregulation encoding DNA replication proteins in 5-Fu resistant colorectal cancer cells［J］．Oncotarget,2017,8(34):56546-56557.
［39］ SINGH P P，SHI Q，FOSTER N R，et al．Relationship between metformin use and recurrence and survival in patients with resected stage iii colon cancer receiving adjuvant chemotherapy:results from north central cancer treatment group N0147 (Alliance)［J］．Oncologist,2016,21(12):1509-1521.
［40］ MIRANDA V C，BRAGHIROLI M I，FARIA L D，et al．Phase 2 trial of metformin combined with 5-fluorouracil in patients with refractory metastatic colorectal cancer［J］．Clin Colorectal Cancer,2016,15(4):321-328.e1.
相似文献/References:
[1]朱武凌 范秉琳.青年与老年结直肠癌C—erbB一2不同表达与DNA倍体的关系[J].新乡医学院学报,2002,19(03):170.
[2]高俊凤,严军,胡春平,等.二甲双胍对胰岛素抵抗小鼠肝组织中胎球蛋白A 表达及磷脂酰肌醇3-激酶/蛋白激酶B 信号通路的影响[J].新乡医学院学报,2022,39(12):1107.[doi:10.7683/xxyxyxb.2022.12.002]
GAO Junfeng,YAN Jun,HU Chunping,et al.Effect of metformin on the expression of fetuin A and phosphatidylinositol 3-kinase/protein kinase B signal pathway in the liver tissue of insulin resistant mice[J].Journal of Xinxiang Medical University,2022,39(7):1107.[doi:10.7683/xxyxyxb.2022.12.002]
[3]王璧,王战会,韩保卫,等.Runt相关转录因子3在结直肠癌组织中的表达及意义[J].新乡医学院学报,2022,39(12):1127.[doi:10.7683/xxyxyxb.2022.12.005]
WANG Bi,WANG Zhanhui,HAN Baowei,et al.Expression and significance of Runt-related transcription factor 3 in colorectal cancer[J].Journal of Xinxiang Medical University,2022,39(7):1127.[doi:10.7683/xxyxyxb.2022.12.005]
[4]齐光照,李朵璐.细胞色素P450酶CYP2W1研究进展[J].新乡医学院学报,2019,36(7):698.[doi:10.7683/xxyxyxb.2019.07.025]
[5]张国正,连 荣,苗文杰,等.二甲双胍对变应性鼻炎小鼠炎性状态的影响[J].新乡医学院学报,2019,36(8):720.[doi:10.7683/xxyxyxb.2019.08.005]
ZHANG Guo-zheng,LIAN Rong,MIAO Wen-jie,et al.Effects of metformin on the inflammatory state in mice with variant rhinitis[J].Journal of Xinxiang Medical University,2019,36(7):720.[doi:10.7683/xxyxyxb.2019.08.005]
[6]李怡春,张 敏,杨晓煜,等.CD133在人结直肠癌组织中的表达及其与缺氧诱导因子1α和核心蛋白聚糖的相关性[J].新乡医学院学报,2019,36(11):1036.[doi:10.7683/xxyxyxb.2019.11.007]
LI Yi-chun,ZHANG Min,YANG Xiao-yu,et al.Expression of CD133 in human colorectal cancer tissues and correlation with hypoxia-induced factor-1α and decorin[J].Journal of Xinxiang Medical University,2019,36(7):1036.[doi:10.7683/xxyxyxb.2019.11.007]
[7]平贯芳,熊万成,邓智建.长链非编码RNA 浆细胞瘤转化迁移基因1在结直肠癌组织和细胞中的表达及临床意义[J].新乡医学院学报,2019,36(10):949.[doi:10.7683/xxyxyxb.2019.10.011]
PING Guan-fang,XIONG Wan-cheng,DENG Zhi-jian.Expression and clinical significance of long-chain non-coding RNA plasmacytoma variant translocation gene 1 in colorectal cancer tissues and cells[J].Journal of Xinxiang Medical University,2019,36(7):949.[doi:10.7683/xxyxyxb.2019.10.011]
[8]姬颖华,杨晓煜,孟祥丽,等.盐酸安罗替尼联合信迪利单抗治疗标准治疗失败后微卫星稳定型结直肠癌疗效观察[J].新乡医学院学报,2021,38(8):719.[doi:10.7683/xxyxyxb.2021.08.004]
JI Yinghua,YANG Xiaoyu,MENG Xiangli,et al.Clinical efficacy of Anlotinib hydrochloride combined with Sintilimab in the treatment of microsatellite stable colorectal cancer after the failure of standard treatment[J].Journal of Xinxiang Medical University,2021,38(7):719.[doi:10.7683/xxyxyxb.2021.08.004]
[9]马 晓,陈国荣,李君艳,等.外周血中性粒细胞与淋巴细胞比值及血清癌胚抗原、糖类抗原199联合检测对结直肠癌的诊断价值[J].新乡医学院学报,2021,38(1):062.[doi:10.7683/xxyxyxb.2021.01.013]
MA Xiao,CHEN Guorong,LI Junyan,et al.Value of combined detection of neutrophil-lymphocyte ratio in peripheral blood,serum carcinoembryonic antigen and carbohydrate antigen 199 in the diagnosis of colorectal cancer[J].Journal of Xinxiang Medical University,2021,38(7):062.[doi:10.7683/xxyxyxb.2021.01.013]
[10]谢 阳,赵李红,杨昌建,等.不同肺复张策略治疗腹腔镜下结直肠癌根治术患者围手术期肺不张疗效观察[J].新乡医学院学报,2021,38(9):857.[doi:10.7683/xxyxyxb.2021.09.012]
XIE Yang,ZHAO Lihong,YANG Changjian,et al.Effect of different lung recruitment strategies in treatment of perioperative atelectasis of patients undergoing laparoscopic radical resection of colorectal cancer[J].Journal of Xinxiang Medical University,2021,38(7):857.[doi:10.7683/xxyxyxb.2021.09.012]